Matteo Casenghi (@mcasenghi) 's Twitter Profile
Matteo Casenghi

@mcasenghi

Interventional Cardiologist @ University of Rome “La Sapienza”

ID: 1224042518347702279

calendar_today02-02-2020 18:51:08

81 Tweet

139 Followers

213 Following

Improving Heart Function (iHF) (@iheartfunction) 's Twitter Profile Photo

🆕 Part 2 of the challenging #heartfailure case shared by Saleh Altaf and Dr Owais H Dar is now online. A man in his 30s with a significant cardiac history and three hospitalisations in six months presented with acute decompensation of advanced HF. 🔍 Explore the decision-making

Matteo Casenghi (@mcasenghi) 's Twitter Profile Photo

🔬 New study on TAVI with Navitor THV available at: authors.elsevier.com/a/1l3075XJLHAR… 🫀 Key procedural predictors of PPI: ✔️ Implantation depth >4 mm ✔️ Oversizing ≥15% (new cut-off) 📉 Excellent hemodynamics (mean gradient: 6 mmHg) #TAVI #StructuralHeart

🔬 New study on TAVI with Navitor THV available at: authors.elsevier.com/a/1l3075XJLHAR…

🫀 Key procedural predictors of PPI:
✔️ Implantation depth >4 mm
✔️ Oversizing ≥15% (new cut-off)

📉 Excellent hemodynamics (mean gradient: 6 mmHg)

#TAVI #StructuralHeart
Improving Heart Function (iHF) (@iheartfunction) 's Twitter Profile Photo

iHF at #EuroPCR 2025 – Mark your calendars! Join the conversation on solution-oriented, innovative approaches to #HeartFailure in our 3 dedicated sessions on improving heart function. See the detailed programme👉bit.ly/43169S8 #ImprovingHeartFunction Emanuele Barbato

iHF at #EuroPCR 2025 – Mark your calendars!

Join the conversation on solution-oriented, innovative approaches to #HeartFailure in our 3 dedicated sessions on improving heart function.
See the detailed programme👉bit.ly/43169S8
#ImprovingHeartFunction <a href="/EmanueleBarba13/">Emanuele Barbato</a>
JACC Journals (@jaccjournals) 's Twitter Profile Photo

Both intra-annular transcatheter heart valves were associated with similar 1-year clinical outcomes; however, differences were observed in secondary clinical endpoints and valve hemodynamic performance. jacc.org/doi/10.1016/j.… #EuroPCR #JACCINT #NAVULTRA #TAVR

Both intra-annular transcatheter heart valves were associated with similar 1-year clinical outcomes; however, differences were observed in secondary clinical endpoints and valve hemodynamic performance. jacc.org/doi/10.1016/j.…

#EuroPCR #JACCINT #NAVULTRA #TAVR
Pasquale Paolisso (@p_paolisso) 's Twitter Profile Photo

Proud of the amazing Teamwork by the entire Cardiology Team at #AziendaOspedalieraSantAndrea for the two Live Cases broadcast globally during #EuroPCR2025. This is a significant recognition of the teamwork, expertise, and innovation we bring to patient care every day!! 🔥🔥🔥

Proud of the amazing Teamwork by the entire Cardiology Team at #AziendaOspedalieraSantAndrea for the two Live Cases broadcast globally during #EuroPCR2025. This is a significant recognition of the teamwork, expertise, and innovation we bring to patient care every day!! 🔥🔥🔥
Improving Heart Function (iHF) (@iheartfunction) 's Twitter Profile Photo

💡Fast-track GDMT optimisation in #HFrEF? Let’s talk strategies with Emanuele Barbato, Giuseppe Rosano, Philipp Lurz & Alexandre Mebazaa! The 🆕 #ImprovingHeartFunction webinar brings you expert-led, practical insights to enhance therapy uptake and patient outcomes. 🗓️19 June 2025 18:00

Pasquale Paolisso (@p_paolisso) 's Twitter Profile Photo

🎯To evaluate the impact of #SGLT2i on the risk of acute kidney injury (AKI) in #T2DM pts w/ severe #AS undergoing #TAVI. 👥 Multicenter Registry of consecutive pts stratified by the presence of CKD and anti-diabetic therapy (2021-2024). 🔥Our main findings were: - SGLT2i

🎯To evaluate the impact of #SGLT2i on the risk of acute kidney injury (AKI) in #T2DM pts w/ severe #AS undergoing #TAVI. 

👥 Multicenter Registry of consecutive pts stratified by the presence of CKD and anti-diabetic therapy (2021-2024). 

🔥Our main findings were: 
- SGLT2i
Improving Heart Function (iHF) (@iheartfunction) 's Twitter Profile Photo

Delayed initiation of lipid-lowering therapy in addition to statins after MI is associated with an increased risk of major CV events compared to early initiation, according to data from the SWEDEHEART registry published in JACC. 🔗iheartfunction.com/news/following…

Delayed initiation of lipid-lowering therapy in addition to statins  after MI is associated with an increased risk of  major CV events compared to early initiation, according to data from the SWEDEHEART registry published in JACC.

🔗iheartfunction.com/news/following…
Improving Heart Function (iHF) (@iheartfunction) 's Twitter Profile Photo

🚫Therapeutic impasse? Not anymore. Refractory heart failure is becoming a catalyst for change — in strategy, in collaboration, and in outcomes. 🔍 Emanuele Barbato & Alexandre Mebazaa dive into the power of combining pharmacological advances with device-based therapies in a

🚫Therapeutic impasse? Not anymore.
Refractory heart failure is becoming a catalyst for change — in strategy, in collaboration, and in outcomes.

🔍 <a href="/EmanueleBarba13/">Emanuele Barbato</a>  &amp; <a href="/AlexMebazaa/">Alexandre Mebazaa</a> dive into the power of combining pharmacological advances with device-based therapies in a
Improving Heart Function (iHF) (@iheartfunction) 's Twitter Profile Photo

🆕 New Journal Club! Jolie Bruno, M.D. & Alexandre Mebazaa Mebazaa break down the CONFIDENCE trial (published in the NEJM): 💊 Finerenone + Empagliflozin in CKD + T2D. 📖Study insights & results here👉bit.ly/45NrJMY

🆕 New Journal Club! <a href="/Jolie_Bruno_/">Jolie Bruno, M.D.</a>  &amp; <a href="/AlexMebazaa/">Alexandre Mebazaa</a>  Mebazaa break down the CONFIDENCE trial (published in the <a href="/NEJM/">NEJM</a>):
💊 Finerenone + Empagliflozin in CKD + T2D.

📖Study insights &amp; results here👉bit.ly/45NrJMY
Improving Heart Function (iHF) (@iheartfunction) 's Twitter Profile Photo

Can dapagliflozin improve function & QoL in patients with systemic right ventricular HF? This latest piece explores the potential of #SGLT2 inhibitors in a tough-to-treat group. Read more👉 bit.ly/45O0WjF #ImprovingHeartFunction #CardioEd

Can dapagliflozin improve function &amp; QoL in patients with systemic right ventricular HF?

This latest piece explores the potential of #SGLT2 inhibitors in a tough-to-treat group.
Read more👉 bit.ly/45O0WjF
#ImprovingHeartFunction #CardioEd
Improving Heart Function (iHF) (@iheartfunction) 's Twitter Profile Photo

🌟 A new course. A new perspective on heart failure care. 📍 Madrid | March 20–21, 2026 Join us for Improving Heart Function an interactive, multidisciplinary event bringing together experts from all fields to reshape the way we treat heart failure. 🎥 Hear from leading voices in

Giuseppe Rosano (@gmcrosano) 's Twitter Profile Photo

We hope you will join us for this unique new Course that will be based on real-world practice in trans-disciplinary care of #heartfailure patients! #ImprovingHeartFunction 2026 iheartfunction.com/improving-hear… Sabine Bleiziffer Emanuele Barbato Alexandre Mebazaa leclercq christophe Improving Heart Function (iHF)

Improving Heart Function (iHF) (@iheartfunction) 's Twitter Profile Photo

At iHF 2026, join practical, hands-on sessions built around what truly matters: real-world cases, drug & device synergy, and actionable tips. Register today and start transforming heart failure management. Watch the video to hear directly from Alexandre Mebazaa brnw.ch/21wW0Dy

Improving Heart Function (iHF) (@iheartfunction) 's Twitter Profile Photo

Be part of the 1st multidisciplinary course on heart failure treatment and revolutionize your practice. Designed for all physicians treating HF, this is your chance to train at an unbeatable price – register before September 30, after that, fees go up! brnw.ch/21wW3hs

Be part of the 1st multidisciplinary course on heart failure treatment and revolutionize your practice.  Designed for all physicians treating HF, this is your chance to train at an unbeatable price – register before September 30, after that, fees go up! brnw.ch/21wW3hs
Pasquale Paolisso (@p_paolisso) 's Twitter Profile Photo

We’re delighted to present our clinical case from the Cardiology Unit at Sant’Andrea University Hospital, showcasing the multidisciplinary management of a patient with HFrEF and multiple Valvular Heart Diseases. A special thank you to the Improving Heart Function (iHF) (iHF) Educational